CMS has released the Q3 2019 drug pricing files for both average sales price (ASP) and not otherwise classified (NOC) drugs. These changes are effective July 1, 2019 and will remain in effect until either a correction or the next scheduled update is made by CMS.

The data used for the Q3 2019 reimbursement files is based on the Q1 2019 sales data submitted to CMS by drug manufacturers. We encourage you to review the revised drug payment limit files, including reimbursement allowables on NOC drugs, on the CMS website.

Access the Payment Limit Report